A Wealth of Experience

We have collaborated with our clients on projects to research hematology, hematologic treatments, and complications and comorbidities of hematologic diseases. Our experience includes:

  • Allogeneic cord blood therapy 
  • Anemia
  • Blood transfusions
  • Hemophilia A
  • Hemophilia B
  • Myelofibrosis
  • Neutropenia
  • Polycythemia Vera
  • Pulmonary and venous embolism
  • Thrombocytopenia

Types of Projects

We have implemented studies to help our clients develop strategies in the hematology market and to develop and gain 
market access for products to treat hematologic diseases and complications arising from treatment of hematologic diseases.

Recent projects have included:

Our Experts

Shahnaz Khan
Senior Director, Market Access and Outcomes Strategy
Caroline Ling
Senior Director, Market Access and Outcomes Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Joan Fortuny
Director, Epidemiology
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Xiaolei Zhou
Director, Biostatistics, US
Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Annete Njue
Director, Market Access and Outcomes Strategy
Lia Gutierrez
Director, Epidemiology
Alicia Gilsenan
Senior Director, Epidemiology
Anne Heyes
Head, Market Access and Outcomes Strategy, Europe
Christopher Knight
Senior Director, Health Economics
Will Herring
Director, Health Economics
Sorrel Wolowacz
Head, European Health Economics
Isobel Pearson
Director, Health Economics, Health Technology Assessment
Jin Yang
Sr. Associate, Market Access and Outcomes Strategy
Susan Hogue
Head, Value Insight and Access Strategy
James Kaye
Senior Director, Epidemiology
Keith Davis
Senior Director, Health Economics
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Matthew Cawson
Senior Research Health Economist